US imposes anti-dumping duties on Tris and Tris HCl from China
The US Department of Commerce has issued final anti-dumping duty determinations on Tris (Hydroxymethyl) Aminomethane and its hydrochloride form (Tris and Tris HCl) imported from China, effective June 10, 2026. These chemicals, used in pharmaceuticals, diagnostics, and industrial applications, will face duties to counteract alleged dumping practices. Importers of these products must adjust landed cost calculations and sourcing strategies immediately.
Photo: Stanley Kissinger / PexelsUS Imposes Anti-Dumping Duties on Tris and Tris HCl from China
On June 10, 2026, the US Department of Commerce published final anti-dumping duty determinations on Tris (Hydroxymethyl) Aminomethane and Tris (Hydroxymethyl) Aminomethane Hydrochloride (Tris and Tris HCl) from China in the Federal Register. This action concludes a formal investigation into alleged dumping of these specialty chemicals and establishes binding duty rates for future imports.
Tris and Tris HCl are fine chemicals used predominantly in pharmaceutical formulations, laboratory reagents, diagnostic kits, and specialty industrial processes. These products typically enter the US under HS Chapter 29 (organic chemicals). The anti-dumping investigation was initiated due to injury to the domestic US chemical industry, with producers arguing that Chinese suppliers were selling at prices below fair value.
The Department of Commerce has determined that Tris and Tris HCl from China are being, or are likely to be, sold at less than fair value, warranting the imposition of anti-dumping duties.
Importers and distributors of Tris and Tris HCl face immediate cost increases. The exact duty rate(s) will be assessed on each shipment and must be declared on the customs entry. Existing contracts negotiated before the June 10 effective date may be affected depending on force-majeure and tariff-cost-pass-through clauses. Chinese manufacturers and their distributors worldwide must now price their US sales to account for these duties, reducing their competitive advantage and potentially shifting market share to domestic and non-Chinese suppliers.
For companies manufacturing pharmaceuticals, diagnostics, or specialty chemicals that depend on imported Tris or Tris HCl, landed cost has risen materially. Procurement teams should immediately evaluate sourcing alternatives—including domestic suppliers, FTA partners, or non-Chinese origins—to mitigate the impact. Those locked into Chinese supply contracts should begin renegotiations with suppliers to share the duty burden or transition to alternative materials where feasible.
What this means for shippers
All shipments of Tris and Tris HCl from China entering the US are now subject to anti-dumping duties effective immediately. Update your landed-cost model and inform suppliers, manufacturers, and customers of the new duty liability. Verify HS classification (Chapter 29) and origin declaration on every shipment to ensure correct duty assessment. If you ship Tris or Tris HCl, recalculate pricing and lead times at once—delay costs money and market share. Use our landed-cost tool to model the impact and identify savings opportunities through alternative sourcing or product reformulation.
